Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1994-12-2
|
pubmed:abstractText |
In order to better define potential mechanisms of growth regulation in human prostate cancer cells, we have compared biological responses (such as short-term response to both transforming growth factor alpha and beta; TFG alpha and TFG beta) in relation to hormone sensitivity of LNCaP, DU145, and PC3 cells. Androgen receptor (AR) and epidermal growth factor receptor (EGF-R) content of each cell line was also investigated. In addition, expression of EGF, TGF alpha, and TGF beta was evaluated through immunofluorescent staining. Growth of androgen non-responsive PC3 cells was stimulated by TGF alpha (about 35%) and inhibited by TGF beta (more than 50%), with respect to controls, after 48 h exposure. Conversely, AR-positive, hormone-responsive LNCaP cells proved to be poorly sensitive, at least short-term, to either growth factor. Furthermore, high levels of both EGF-R and TGF alpha, and a fairly high amount of EGF, were found in DU145 cells and, to a lesser extent, in LNCaP cells; in contrast, PC3 cells exhibited low expression levels of both receptors (EGF-R) and ligands (EGF, TGF alpha), but displayed remarkable TGF beta binding and relatively high levels of endogenous TGF beta. Overall, these results suggest a differential sensitivity to TGF alpha and TGF beta by prostate cancer cells; TGF alpha response seems not to be proportional to the EGF-R content of individual cell lines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Androgens,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Androgen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0039-128X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
412-20
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7974525-Androgens,
pubmed-meshheading:7974525-Cell Division,
pubmed-meshheading:7974525-Fluorescent Antibody Technique,
pubmed-meshheading:7974525-Humans,
pubmed-meshheading:7974525-Male,
pubmed-meshheading:7974525-Prostatic Neoplasms,
pubmed-meshheading:7974525-Receptors, Androgen,
pubmed-meshheading:7974525-Receptors, Growth Factor,
pubmed-meshheading:7974525-Time Factors,
pubmed-meshheading:7974525-Transforming Growth Factor alpha,
pubmed-meshheading:7974525-Transforming Growth Factor beta,
pubmed-meshheading:7974525-Tumor Cells, Cultured
|
pubmed:year |
1994
|
pubmed:articleTitle |
Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells.
|
pubmed:affiliation |
Hormone Biochemistry Laboratory, School of Medicine, University of Palermo, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|